MODULATION OF MESOLIMBIC DOPAMINERGIC BEHAVIORS BY CHOLECYSTOKININ

[1] A DOUBLE-BLIND-STUDY WITH CERULETIDE IN CHRONIC-SCHIZOPHRENIC PATIENTS - BIOCHEMICAL AND CLINICAL-RESULTS [J]. PSYCHIATRY RESEARCH, 1986, 19 (01) : 1 - 7

[2] INCREASE IN BRAIN I-125-LABELED CHOLECYSTOKININ (CCK) RECEPTOR-BINDING FOLLOWING CHRONIC HALOPERIDOL TREATMENT, INTRACISTERNAL 6-HYDROXYDOPAMINE OR VENTRAL TEGMENTAL LESIONS [J]. LIFE SCIENCES, 1983, 32 (08) : 871 - 878

[3] PRESYNAPTIC REGULATION OF NEUROTRANSMITTER RELEASE IN THE BRAIN - FACTS AND HYPOTHESIS [J]. NEUROSCIENCE, 1984, 12 (02) : 347 - 375

[4] PROGLUMIDE - SELECTIVE ANTAGONISM OF EXCITATORY EFFECTS OF CHOLECYSTOKININ IN CENTRAL NERVOUS-SYSTEM [J]. SCIENCE, 1983, 219 (4591) : 1449 - 1450

[5] EFFECTS OF SELECTIVE DOPAMINE-D2-RECEPTOR AGONISTS ON THE RELEASE OF CHOLECYSTOKININ-LIKE IMMUNOREACTIVITY FROM RAT NEOSTRIATUM [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1984, 101 (1-2) : 119 - 125

[6] DIFFERENTIATION OF DOPAMINE MECHANISMS MEDIATING STEREOTYPED BEHAVIOR AND HYPERACTIVITY IN NUCLEUS ACCUMBENS AND CAUDATE-PUTAMEN [J]. JOURNAL OF PHARMACY AND PHARMACOLOGY, 1977, 29 (06) : 337 - 342

[7] BEHAVIORAL AND NEUROPHYSIOLOGICAL EVIDENCE FOR A FACILATORY INTERACTION BETWEEN CO-EXISTING TRANSMITTERS - CHOLECYSTOKININ AND DOPAMINE [J]. NEUROCHEMISTRY INTERNATIONAL, 1984, 6 (06) : 755 - 760

[8] CRAWLEY JN, 1985, J NEUROSCI, V5, P1972

[9] TOPOGRAPHICAL ANALYSIS OF NUCLEUS ACCUMBENS SITES AT WHICH CHOLECYSTOKININ POTENTIATES DOPAMINE-INDUCED HYPERLOCOMOTION IN THE RAT [J]. BRAIN RESEARCH, 1985, 335 (02) : 337 - 341

[10] CRAWLEY JN, 1986, J PHARMACOL EXP THER, V236, P320

[1] A DOUBLE-BLIND-STUDY WITH CERULETIDE IN CHRONIC-SCHIZOPHRENIC PATIENTS - BIOCHEMICAL AND CLINICAL-RESULTS [J]. PSYCHIATRY RESEARCH, 1986, 19 (01) : 1 - 7

[2] INCREASE IN BRAIN I-125-LABELED CHOLECYSTOKININ (CCK) RECEPTOR-BINDING FOLLOWING CHRONIC HALOPERIDOL TREATMENT, INTRACISTERNAL 6-HYDROXYDOPAMINE OR VENTRAL TEGMENTAL LESIONS [J]. LIFE SCIENCES, 1983, 32 (08) : 871 - 878

[3] PRESYNAPTIC REGULATION OF NEUROTRANSMITTER RELEASE IN THE BRAIN - FACTS AND HYPOTHESIS [J]. NEUROSCIENCE, 1984, 12 (02) : 347 - 375

[4] PROGLUMIDE - SELECTIVE ANTAGONISM OF EXCITATORY EFFECTS OF CHOLECYSTOKININ IN CENTRAL NERVOUS-SYSTEM [J]. SCIENCE, 1983, 219 (4591) : 1449 - 1450

[5] EFFECTS OF SELECTIVE DOPAMINE-D2-RECEPTOR AGONISTS ON THE RELEASE OF CHOLECYSTOKININ-LIKE IMMUNOREACTIVITY FROM RAT NEOSTRIATUM [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1984, 101 (1-2) : 119 - 125

[6] DIFFERENTIATION OF DOPAMINE MECHANISMS MEDIATING STEREOTYPED BEHAVIOR AND HYPERACTIVITY IN NUCLEUS ACCUMBENS AND CAUDATE-PUTAMEN [J]. JOURNAL OF PHARMACY AND PHARMACOLOGY, 1977, 29 (06) : 337 - 342

[7] BEHAVIORAL AND NEUROPHYSIOLOGICAL EVIDENCE FOR A FACILATORY INTERACTION BETWEEN CO-EXISTING TRANSMITTERS - CHOLECYSTOKININ AND DOPAMINE [J]. NEUROCHEMISTRY INTERNATIONAL, 1984, 6 (06) : 755 - 760

[8] CRAWLEY JN, 1985, J NEUROSCI, V5, P1972

[9] TOPOGRAPHICAL ANALYSIS OF NUCLEUS ACCUMBENS SITES AT WHICH CHOLECYSTOKININ POTENTIATES DOPAMINE-INDUCED HYPERLOCOMOTION IN THE RAT [J]. BRAIN RESEARCH, 1985, 335 (02) : 337 - 341

[10] CRAWLEY JN, 1986, J PHARMACOL EXP THER, V236, P320